Immunology

Delayed antibody treatment may improve efficacy of mRNA vaccines

Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and ...

Diseases, Conditions, Syndromes

'Assassin' cells found to play a key role in deadly drug reactions

Researchers have identified the skin cells responsible for orchestrating cases of two of the most life-threatening drug reactions. Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) cause the skin and mucous ...

page 2 from 40